Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancer

Robert Mauritz, Cees J. Van Groeningen, Kees Smid, Gerrit Jansen, Herbert M. Pinedo, Godefridus J. Peters

Research output: Contribution to journalArticle

Abstract

This study explores the effect of 5-fluorouracil (5FU) exposure on mRNA levels of its target enzyme thymidylate synthase (TS) and the rate-limiting catabolic enzyme dihydropyrimidine dehydrogenase (DPD) in tumors of colorectal cancer patients. TS and DPD mRNA levels were determined in primary tumor and liver metastasis samples from patients who were either not pretreated (n = 29) or given one presurgery bolus of 5FU (n = 67). In both groups a wide variation in TS mRNA levels was observed. Median TS mRNA expression in 17 primary tumors of exposed patients was 3.0-fold higher than in 19 primary tumors of unexposed patients (p = 0.015). TS mRNA expression in liver metastasis samples of exposed patients (n = 16) was also higher (5.2-fold) than that of unexposed patients (n = 48; p <0.001). Also DPD mRNA express ion displayed a large degree of interpatient variation. No difference in DPD expression in liver metastasis samples was observed between exposed and unexposed patients. However, median DPD mRNA expression in 15 primary tumors of exposed patients was 3.2-fold lower than in 18 primary tumors of unexposed patients (p = 0.027). In conclusion, administration of 5FU in vivo influences the gene expression of TS and DPD.

Original languageEnglish (US)
Pages (from-to)2609-2612
Number of pages4
JournalInternational Journal of Cancer
Volume120
Issue number12
DOIs
StatePublished - Jun 15 2007
Externally publishedYes

Fingerprint

Dihydrouracil Dehydrogenase (NADP)
Thymidylate Synthase
Fluorouracil
Colorectal Neoplasms
Messenger RNA
Neoplasms
Neoplasm Metastasis
Liver
Enzymes
Ions

Keywords

  • 5-fluorouracil
  • Colorectal carcinoma
  • Dihydropyrimidine dehydrogenase
  • RT-PCR
  • Thymidylate synthase

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancer. / Mauritz, Robert; Van Groeningen, Cees J.; Smid, Kees; Jansen, Gerrit; Pinedo, Herbert M.; Peters, Godefridus J.

In: International Journal of Cancer, Vol. 120, No. 12, 15.06.2007, p. 2609-2612.

Research output: Contribution to journalArticle

Mauritz, Robert ; Van Groeningen, Cees J. ; Smid, Kees ; Jansen, Gerrit ; Pinedo, Herbert M. ; Peters, Godefridus J. / Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancer. In: International Journal of Cancer. 2007 ; Vol. 120, No. 12. pp. 2609-2612.
@article{f5c731d39ea449128d2f7ea026e0ca5a,
title = "Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancer",
abstract = "This study explores the effect of 5-fluorouracil (5FU) exposure on mRNA levels of its target enzyme thymidylate synthase (TS) and the rate-limiting catabolic enzyme dihydropyrimidine dehydrogenase (DPD) in tumors of colorectal cancer patients. TS and DPD mRNA levels were determined in primary tumor and liver metastasis samples from patients who were either not pretreated (n = 29) or given one presurgery bolus of 5FU (n = 67). In both groups a wide variation in TS mRNA levels was observed. Median TS mRNA expression in 17 primary tumors of exposed patients was 3.0-fold higher than in 19 primary tumors of unexposed patients (p = 0.015). TS mRNA expression in liver metastasis samples of exposed patients (n = 16) was also higher (5.2-fold) than that of unexposed patients (n = 48; p <0.001). Also DPD mRNA express ion displayed a large degree of interpatient variation. No difference in DPD expression in liver metastasis samples was observed between exposed and unexposed patients. However, median DPD mRNA expression in 15 primary tumors of exposed patients was 3.2-fold lower than in 18 primary tumors of unexposed patients (p = 0.027). In conclusion, administration of 5FU in vivo influences the gene expression of TS and DPD.",
keywords = "5-fluorouracil, Colorectal carcinoma, Dihydropyrimidine dehydrogenase, RT-PCR, Thymidylate synthase",
author = "Robert Mauritz and {Van Groeningen}, {Cees J.} and Kees Smid and Gerrit Jansen and Pinedo, {Herbert M.} and Peters, {Godefridus J.}",
year = "2007",
month = "6",
day = "15",
doi = "10.1002/ijc.22626",
language = "English (US)",
volume = "120",
pages = "2609--2612",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancer

AU - Mauritz, Robert

AU - Van Groeningen, Cees J.

AU - Smid, Kees

AU - Jansen, Gerrit

AU - Pinedo, Herbert M.

AU - Peters, Godefridus J.

PY - 2007/6/15

Y1 - 2007/6/15

N2 - This study explores the effect of 5-fluorouracil (5FU) exposure on mRNA levels of its target enzyme thymidylate synthase (TS) and the rate-limiting catabolic enzyme dihydropyrimidine dehydrogenase (DPD) in tumors of colorectal cancer patients. TS and DPD mRNA levels were determined in primary tumor and liver metastasis samples from patients who were either not pretreated (n = 29) or given one presurgery bolus of 5FU (n = 67). In both groups a wide variation in TS mRNA levels was observed. Median TS mRNA expression in 17 primary tumors of exposed patients was 3.0-fold higher than in 19 primary tumors of unexposed patients (p = 0.015). TS mRNA expression in liver metastasis samples of exposed patients (n = 16) was also higher (5.2-fold) than that of unexposed patients (n = 48; p <0.001). Also DPD mRNA express ion displayed a large degree of interpatient variation. No difference in DPD expression in liver metastasis samples was observed between exposed and unexposed patients. However, median DPD mRNA expression in 15 primary tumors of exposed patients was 3.2-fold lower than in 18 primary tumors of unexposed patients (p = 0.027). In conclusion, administration of 5FU in vivo influences the gene expression of TS and DPD.

AB - This study explores the effect of 5-fluorouracil (5FU) exposure on mRNA levels of its target enzyme thymidylate synthase (TS) and the rate-limiting catabolic enzyme dihydropyrimidine dehydrogenase (DPD) in tumors of colorectal cancer patients. TS and DPD mRNA levels were determined in primary tumor and liver metastasis samples from patients who were either not pretreated (n = 29) or given one presurgery bolus of 5FU (n = 67). In both groups a wide variation in TS mRNA levels was observed. Median TS mRNA expression in 17 primary tumors of exposed patients was 3.0-fold higher than in 19 primary tumors of unexposed patients (p = 0.015). TS mRNA expression in liver metastasis samples of exposed patients (n = 16) was also higher (5.2-fold) than that of unexposed patients (n = 48; p <0.001). Also DPD mRNA express ion displayed a large degree of interpatient variation. No difference in DPD expression in liver metastasis samples was observed between exposed and unexposed patients. However, median DPD mRNA expression in 15 primary tumors of exposed patients was 3.2-fold lower than in 18 primary tumors of unexposed patients (p = 0.027). In conclusion, administration of 5FU in vivo influences the gene expression of TS and DPD.

KW - 5-fluorouracil

KW - Colorectal carcinoma

KW - Dihydropyrimidine dehydrogenase

KW - RT-PCR

KW - Thymidylate synthase

UR - http://www.scopus.com/inward/record.url?scp=34247494666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247494666&partnerID=8YFLogxK

U2 - 10.1002/ijc.22626

DO - 10.1002/ijc.22626

M3 - Article

VL - 120

SP - 2609

EP - 2612

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 12

ER -